6990-06-3 Usage
Description
Fusidine, also known as Fusidic Acid, is a steroid antibiotic derived from the fermentation broth of Fusidium coccineum. It is a white solid with bacteriostatic properties, which means it can inhibit the growth of bacteria rather than killing them. Fusidine works by suppressing nitric oxide lysis of pancreatic islet cells and inhibiting protein synthesis in prokaryotes by inhibiting the ribosome-dependent activity of G factor and translocation of peptidyl-tRNA.
Uses
Used in Pharmaceutical Industry:
Fusidine is used as an antibacterial agent for its bacteriostatic properties. It is particularly effective in inhibiting the growth of bacteria by suppressing nitric oxide lysis of pancreatic islet cells and inhibiting protein synthesis in prokaryotes.
Used in Dyes and Metabolites Industry:
Fusidine is also used in the production of dyes and metabolites due to its chemical properties.
Brand Name:
Fucidine (Bristol-Myers Squibb) is a brand name under which Fusidine is marketed.
Mode of action
Fusidic acid forms a stable complex with an elongation factor (EF-G) involved in translocation and with guanosine triphosphate (GTP), which provides energy for the translocation process. One round of translocation occurs, with hydrolysis of GTP, but the fusidic acid–EF-G–GDP complex cannot dissociate from the ribosome, thereby blocking further chain elongation and leaving peptidyl-tRNA in the P site.
Although protein synthesis in Gram-negative bacilli–and, indeed, mammalian cells–is susceptible to fusidic acid, the antibiotic penetrates poorly into these cells and the spectrum of action is virtually restricted to Gram-positive bacteria, notably staphylococci.
Hazard
Moderately toxic inhibitor of translocation
during protein synthesis.
Biochem/physiol Actions
Fusidic acid is a tetracyclic triterpenoid with antibiotic activity against Gram-positive bacteria. It is derived from Fusidium coccineum. It shows its activity against anaerobes, corynebacterial, Nocardia, and Neisseria species. Fusidic acid exhibits therapeutic effects against Staphylococcal infections, skin infections.
Check Digit Verification of cas no
The CAS Registry Mumber 6990-06-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,9 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6990-06:
(6*6)+(5*9)+(4*9)+(3*0)+(2*0)+(1*6)=123
123 % 10 = 3
So 6990-06-3 is a valid CAS Registry Number.
InChI:InChI=1/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20+/t18-,21-,22-,23+,24+,25-,27?,29-,30-,31-/m0/s1
6990-06-3Relevant articles and documents
Fusidic acid ring B hydroxylation by Cunninghamella elegans
Ibrahim, Abdel-Rahim S.,Ragab, Amany E.
, p. 86 - 89 (2018/04/14)
Fusidic acid (1) biotransformation using the fungus Cunninghamella elegans NRRL 1392 was studied. Two hydroxylated derivatives of fusidic acid (2, 3) were isolated, and their structures were fully elucidated using various spectroscopic techniques includin
Glycosylated analogs of fusidic acid
-
, (2008/06/13)
Novel analogs of fusidic acid are described with one or more carbohydrate units attached. Certain glycosylated analogs of fusidic acid have enhanced solubility properties in diluents or excipient of choice as compared to unmodified fusidic acid. Certain glycosylated analogs may be employed as chemotherapeutic agents and particular analogs may be useful for fighting anti-microbial infections.